Positive Inotropic Effects of Imidazoline Derivatives Are Not Mediated via Imidazoline Binding Sites butα1-Adrenergic Receptors

DOI Web Site Web Site Web Site Web Site ほか1件をすべて表示 一部だけ表示 参考文献68件
  • Raasch Walter
    Institute of Experimental and Clinical Pharmacology and Toxicology,Medical University of Lübeck,Ratzeburger Allee 160,D-23538 Lübeck,Germany
  • Chun K.R.Julian
    Institute of Experimental and Clinical Pharmacology and Toxicology,Medical University of Lübeck,Ratzeburger Allee 160,D-23538 Lübeck,Germany
  • Dendorfer Andreas
    Institute of Experimental and Clinical Pharmacology and Toxicology,Medical University of Lübeck,Ratzeburger Allee 160,D-23538 Lübeck,Germany
  • Dominiak Peter
    Institute of Experimental and Clinical Pharmacology and Toxicology,Medical University of Lübeck,Ratzeburger Allee 160,D-23538 Lübeck,Germany

書誌事項

タイトル別名
  • Positive Inotropic Effects of Imidazoline Derivatives Are Not Mediated via Imidazoline Binding Sites but .ALPHA.1-Adrenergic Receptors.
  • Positive Inotropic Effects of Imidazoline Derivatives Are Not Mediated via Imidazoline Binding Sites but アルファ 1 Adrenergic Receptors

この論文をさがす

抄録

Imidazoline−binding sites are non−adrenergic receptors and classified into I1/I2 subtypes.There is strong evidence that I1−binding sites, located in the rostro−ventrolateral medulla, are involved in regulation of blood pressure.However, less is known about the peripheral participation of I1−binding sites in cardiovascular reactions.Therefore, the aim of this study was to investigate whether specific imidazoline derivatives influence myocardial contractility and whether imidazoline binding sites are expressed in rat heart.Agmatine, clonidine and idazoxan failed to alter inotropy in left atria within the whole concentration range tested(1 nM−100μM), whereas cirazoline(1−100μM)and moxonidine(100μM)increase inotropy by about 20−30%.After pre−incubation with the α1−adrenoceptor antagonist prazosin, the cirazoline and moxonidine stimulated inotropy was antagonized, indicating more an α1−adrenergic and less an imidazoline binding site mediated mechanism.Radioligand−binding studies in membranes of left ventricles using [3H]−clonidine to specify I1−binding yielded KD values of 12.7μM, confirming the functional results of an absence of I1−binding sites in ventricles of rats.However, the existence of low affinity I2−binding sites determined by [3H]−idazoxan labeling could not be excluded since a KD of 0.5μM was calculated and since competition studies with guanabenz(Ki=0.1μM), clonidine(Ki=58.1μM)and moxonidine(Ki=129μM)confirmed the specificity of the I2−binding.

収録刊行物

  • Jpn.J.Pharmacol.

    Jpn.J.Pharmacol. 84 (1), 1-6, 2000

    公益社団法人 日本薬理学会

参考文献 (68)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ